Tiziana Life Sciences Investor Presentation — August 2020

Document content

An Innovative Platform in Oral, Nasal and Inhalation

for Monoclonal Antibody Administration

Proprietary inhalation delivery of anti -IL-6R mAb for

Advanced clinical programs in Crohn ’s Disease,

progressive Multiple Sclerosis, and Hepatocellular

Corporate Presentation

NASDAQ: TLSA AIM: TILS https://www.tizianalifesciences.com/

DISCLAIMER AND FORWARD LOOKING STATEMENTS

Thecontent ofthispresentation hasbeen prepared forthepurpose ofproviding general information about, andanoverview of,theCompany anditsbusiness .Itisnot

intended tobeacomplete review ofallmatters concerning theCompany andnorhasitbeen independently verified .Whilst thepresentation hasbeen prepared ingood

faith andtheCompany hastaken allreasonable care toensure theinformation andfacts contained inthispresentation areaccurate andup-to-date, itdoes notmake any

representation orwarranty, express orimplied, astotheaccuracy orcompleteness ofanyinformation included inthispresentation .Neither theCompany noranyofits

directors, officers, employees oragents shall beliable foranylossarising directly orindirectly from theuseoforreliance upon thispresentation orinrelation tothe

adequacy, accuracy, completeness orreasonableness oftheinformation itcontains. Allandanysuch liability isexpressly excluded tothefullest extent permitted bylaw.

Theinformation inthispresentation issubject toupdating, completion, revision, further verification andamendment without notice .

Thispresentation does notconstitute orform partofanyoffer forsaleorsolicitation ofanyoffer tobuyorsubscribe foranysecurities including ordinary shares inthe

Company nordoes itconstitute aninvitation orinducement toengage ininvestment activity inrelation toanysecurities, including theordinary shares oftheCompany. It

does notpurport tocontain information thatshall form thebasis oforberelied upon inmaking such investment decisions. Ifyourequire anyadvice, please consult with a

professional financial adviser .Allinvestments aresubject torisk. Thevalue ofsecurities maygodown aswellasup.Pastperformance cannot berelied onasaguide for

future performance .

Thispresentation maycontain certain forward -looking statements concerning thefinancial condition, results ofoperations andbusinesses oftheCompany. Allstatements

other than statements ofhistorical factare,ormaybedeemed tobe,forward -looking statements .Forward -looking statements arestatements offuture expectations that

arebased onmanagement’s current expectations andassumptions andinvolve known andunknown risks anduncertainties thatcould cause actual results, performance or

events todiffer materially from those expressed orimplied inthese statements .Allforward -looking statements contained inthispresentation areexpressly qualified in